Clinical Trials Logo
  1. Home
  2. Open-Angle Glaucoma
  3. NCT03160690
  4. Details
NCT03160690 Clinical Trial

Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy

Open Angle Glaucoma Clinical Trial

Official title:
Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT03160690
Other study ID # OFT-ENP-2017-03
Secondary ID
Status Not yet recruiting
Phase N/A
First received May 17, 2017
Last updated May 18, 2017
Start date June 17, 2017
Est. completion date May 17, 2018

Study information
Verified date May 2017
Source Germans Trias i Pujol Hospital
Contact Sandra Gómez Sánchez, MD
Phone 0034934978919
Email gomezsanchez.s@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Prospective and observational study to determine if choroidal thickness increases after non penetrating deep sclerectomy in patients with open angle glaucoma

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 20
Est. completion date May 17, 2018
Est. primary completion date November 17, 2017
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Progressive Primary Open Angle Glaucoma

Exclusion Criteria:

- Age under 18yrs

- Myopia or Hyperopia higher than -6D or +6D

- Secondary glaucoma

- Ocular surgery other than cataract

- Other ocular pathology

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Non penetrating deep sclerectomy
Non penetrating deep sclerectomy for open angle glaucoma

Locations
Country Name City State
Spain Germans Trias i Pujol Hospital Badalona Barcelona

Sponsors (5)
Lead Sponsor Collaborator
Germans Trias i Pujol Hospital Jordi Castellví Manent, Jorge Loscos Arenas, Nevena Romanic Bubalo, Pau Romera Romero

Country where clinical trial is conducted

Spain, 

Outcome
Type Measure Description Time frame Safety issue
Primary Change in Choroidal thickness Choroidal thickness measured by optic coherence tomography before and 1 week, 1 month, 3 months and 6 months after non penetrating deep sclerectomy
Primary Change in Intraocular pressure mmHg before and 1 week, 1 month, 3 months and 6 months after non penetrating deep sclerectomy
See also
  Status Clinical Trial Phase
Completed NCT03284853 - Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension Phase 3
Terminated NCT03611530 - CoQun Study - (COQUN): a Study to Evaluate the Effects of CoQun in Patients Affected by Open-angle Glaucoma N/A
Not yet recruiting NCT06441643 - Next Generation Rocklatan Phase 2
Not yet recruiting NCT02868502 - Different Glaucoma Treatments Effect on Intraocular Pressure Fluctuation With Postural Change in Eyes With Open-angle Glaucoma N/A
Completed NCT02272569 - STARflo European Safety and Efficacy Study N/A
Completed NCT02628223 - 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma N/A
Completed NCT01936389 - A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma Phase 2
Completed NCT00941525 - Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure Phase 4
Completed NCT00539526 - Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues Phase 4
Completed NCT00121147 - Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan N/A
Active, not recruiting NCT05035394 - Swedish Microinvasive Glaucoma Surgery Study (SMIGS) N/A
Completed NCT03450629 - Evaluation of Safety and Efficacy of PDP-716 Phase 3
Active, not recruiting NCT06061718 - Travoprost Intraocular Implant in Conjunction With Cataract Surgery Phase 3
Recruiting NCT05241938 - PSLT Compared to Prostaglandin Analogue Eye Drops N/A
Completed NCT01342406 - Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics
Completed NCT02250612 - SYL040012, Treatment for Open Angle Glaucoma Phase 2
Completed NCT01937312 - Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue Phase 4
Completed NCT01937299 - Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z® Phase 4
Terminated NCT01983579 - TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection Phase 4
Completed NCT01229982 - A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma Phase 2